HighCape Capital
HighCape Capital is a growth equity fund established in 2013, dedicated to supporting innovative Life Sciences companies as they transition from early stages to successful enterprises. The firm leverages the extensive experience of its team in founding, financing, and leading Life Sciences companies across various industry segments. HighCape Capital focuses on providing strategic guidance and operational support to its portfolio companies, fostering entrepreneurship and delivering value to its partners and the healthcare system.
What We Do
HighCape Capital provides investment and operating experience and expertise to Life Sciences companies, offering timely and valued insights.
The firm partners with management teams to enhance their commercial and operational strategies, expanding talent and resources as needed.
HighCape Capital is committed to building companies and delivering value, enabling the passion and vision of portfolio company leaders.
Geographic Focus
Industry Focus
Portfolio
Elutia is pioneering drug-eluting biomaterial platforms to address challenges from medical device implant failures.
#Medical Device/Tool
Quantum-Si is a leader in semiconductor chip-based proteomics, providing tools for sample preparation, sequencing, and data analysis.
#Medical Device/Tool
Wellinks develops connected medical devices for respiratory wellness, including the Flyp nebulizer for asthma and COPD management.
#Connected Health
Cybrexa focuses on oncology with its alphalex™ technology for targeted intracellular drug delivery.
#Biotechnology
Alphina develops therapeutics targeting altered states of NAD metabolism for cancer treatment.
#Biotechnology
Cheetah Medical specializes in non-invasive hemodynamic monitoring, acquired by Baxter International in 2019.
#Medical Device/Tool